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Abstract
Background: Intra-articular hyaluronic acid (HA) injection is an intermediate option between analgesics and knee
joint replacement in patients with osteoarthritis (OA). Our objective was to test whether image-guided HA
injections may improve knee OA outcomes after 6 months of treatment independent of potential covariates.
Methods: This is a retrospective case series with multivariate outcome-based analysis of 207 consecutive adult
patients with mild to severe knee OA treated at a single out-patient clinic employing fluoroscopy-guided HA
injections. We employed a customized pain (scored 0–10) and function (scored 0–120) questionnaire based on the
Likert scale to compare baseline scores with 6-month outcomes. Linear and logistic (based on >9-point score
improvement) regression analysis was used to adjust for potential covariates, including grade of disease, patient
age, gender, body mass index, smoking history, medical history (e.g., diabetes or heart disease), use of daily pain
medications, fish oil supplementation, knee bracing, and physical therapy.
Results: Significant covariates included OA grade, knee bracing, and analgesic use. Most of the study subjects were
women (124/207, 60 %) and obese (113/207, 55 %). Clinically significant improvements in index scores (>9 points)
at 6 months were observed in more than 50 % of cases post-image-guided HA injection. Regression analysis
revealed a complimentary affect with knee bracing, especially in severe grade 4 disease (odds ratio 5.5 [1.14–27.0],
P < 0.05). Daily analgesic use reflected a poor clinical response to treatment.
Conclusions: Our data suggest image-guided HA injections coupled with knee bracing may benefit patients with
moderate to severe knee osteoarthritis.
Key Points:
 Image-guided hyaluronic acid injections significantly improve clinical outcomes at 6 months for mild,
moderate, and severe knee osteoarthritis.
 Knee bracing is a significant covariate for clinical improvement in severe grade 4 disease.
 Daily analgesic use is associated with high-grade disease and less clinical improvement.
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Background
Osteoarthritis (OA) of the knee is a leading cause of
adult disability [1], affecting approximately 10–15 % of
Americans over the age of 60 years [2]. The estimated
cost to the United States economy is over $100 billion
per year [3, 4], and the prevalence of the disease is ex-
pected to increase over the next decade due to obesity
and aging of the population.
A wide variety of treatment options are available [5],
including weight loss, knee bracing, physical therapy,
analgesics, intra-articular injections (e.g., hyaluronic acid
[HA], methylprednisolone), and surgery (e.g., debride-
ment or joint replacement). Non-surgical conservative
approaches such as HA injection provide an intermedi-
ate approach between analgesics and joint replacement
with the objective of decreasing pain, improving func-
tion, and delaying the need for joint replacement. Recent
meta-analyses provide conflicting opinions about the
efficacy of HA injections [6–8], which may affect pro-
viders’ willingness to recommend this type of treatment.
However, we suspect many patients may potentially
benefit from image-guided injections [9, 10] after con-
trolling for covariates.
We hypothesized that image-guided intra-articular HA
injections improve 6-month clinical outcomes in adults
with mild to severe knee OA. Moreover, supplemental
knee bracing and analgesic support may improve out-
comes compared with image-guided HA injection alone.
Methods
Study Design
This is a retrospective case series with multivariate
outcome-based analysis using an Oregon Health & Sci-
ence University Institutional Review Board approved
protocol to extract clinical chart data from 207 adult pa-
tients (25–105 years old) with mild (grade 2), moderate
(grade 3), or severe (grade 4) knee OA treated at a single
out-patient clinic in 2013. All study subjects were
Caucasian with 6 months of clinical follow-up after a
series of three fluoroscopy-guided (1.0 ml of IsoVue
contrast injected into the knee with a 21-gauge needle)
HA (Euflexxa, 1 % Sodium Hyaluronate, Ferring Pharm.
Inc. Parsippany, NJ) injections administered 1 week
apart by an experienced physician (RR). Clinical data
were extracted from uniform patient questionnaires
using a customized pain (scored 0–10) and function
(scored 0–120) assessment based on the Likert scale
[7, 11]. Physical examination and clinical history were
screened for potential covariates, including the grade
of osteoarthritis, which was defined by the Kellgren-
Lawrence criteria [12]: grade 2 (mild) had definite joint
space narrowing and osteophytic lipping, grade 3 (moder-
ate) also showed sclerosis and possible bone contour de-
formity, and grade 4 (severe) had severe sclerosis, joint
narrowing, large osteophytes, and bone contour deform-
ities. Patient age, gender, body mass index, smoking his-
tory, significant medical history (e.g., diabetes or heart
disease), subjective reporting of over-the-counter daily an-
algesics (e.g., NSAIDs), daily fish oil supplements, and
duration of disease were also documented. More than half
of the study subjects (110/207) were fitted with a non-
customized single-hinged medial off-loading knee brace
(V/Q OrthoCare, Vista, CA) after HA injection for the
duration of the 6-month interval available for outcome
metrics. Knee bracing was recommended to patients with
limitations in activity defined by the ability to ambulate up
and down a flight of stairs ±knee brace. Physical therapy
was recommended for all study subjects. Of these, 100
study subjects regularly participated in knee-centric phys-
ical therapy (8–10 sessions over 6-month study period).
Patients completed follow-up questionnaires and had a
physical examination at 2 and 6 months post-image-
guided HA injection. This archived patient chart data
was extracted into a coded file without patient identi-
fiers (e.g., name, birthdate) for statistical analysis.
Extraction quality assurance was verified by 10 % inde-
pendent review (20/207 cases).
Statistical Analyses
All statistical analyses were performed using SAS (ver-
sion 9.4, SAS Institute, Cary, NC). Patient demographics,
potential covariates, and outcome metrics were exam-
ined by univariate analysis using the Student t-test.
Potential covariates (e.g., knee bracing, analgesics) were
analyzed as binary variables (yes or no). In the cases with
bilateral knee involvement, the highest OA grade knee
was employed for analysis. The primary outcome metric
was pain and function outcomes at 2 and 6 months
compared with baseline (before first HA injection) for
linear regression analysis, and “clinically significant” im-
provement was defined as >9-point decrease in score for
logistic regression analysis. Subjective pain index (0–10)
was a secondary outcome analyzed by linear regression.
Results
Multivariate regression analysis demonstrated that knee
osteoarthritis grade was the most significant covariate
affecting clinical outcomes at 2 months (P < 0.0001) and
6 months (P < 0.0001) post-image-guided HA injection.
Therefore, all analyses were reported separately for each
OA grade: mild (grade 2), moderate (grade 3), and se-
vere (grade 4) disease (Table 1). As expected, univariate
analysis showed that increasing severity of knee OA was
related to increasing subject age and body mass index.
Most of the study subjects were obese with BMIs ≥30.0
(113/207, 55 %) and most were women (124/207, 60 %).
Univariate analysis did not show a relationship between
OA grade and smoking, daily analgesic use, or physical
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therapy. Moderate to severe OA were more likely to be
fitted with a knee brace. Surprisingly, the greatest fre-
quency of improvement was seen in more severe disease
(68 % of study subjects), which also showed the most
improvement in pain index (40 % compared with 21 %
in mild disease).
Regression analysis revealed that knee bracing pro-
vided a positive complimentary effect to HA injection in
severe OA cases (Table 2) to improve outcomes with an
odds ratio of 5.5 (1.14–27.0) and P value <0.05. Anal-
gesic use reflected a poor clinical response to treatment,
rather than positive additive effect as first postulated.
Physical therapy significantly decreased subjective pain
index for mild OA (P < 0.01), but it had no effect on
moderate or severe disease. Outcomes at 2 months were
not significantly different than 6-month outcomes in this
case series (data not shown) with the exception that bra-
cing appeared to positively affect outcomes in moderate
cases at 2 months (odds ratio 2.17 [0.86–5.48], P value
0.02), which remained a positive effect at 6 months, but
the effect was not statistically significant (Table 2). Mild
OA did not respond to knee bracing at either 2 or
6 months of evaluation, although logistic regression sug-
gested a positive trend (P = 0.19).
Table 1 Patient demographics and outcomes treated by image-guided hyaluronic acid injection
OA grade 2 (n = 58) OA grade 3 (n = 98) OA grade 4 (n = 51) P value X2 or ANOVA
Age (mean, SD) 56.3 ± 12.4 64.0 ± 11.3 69.8 ± 12.2 P < 0.0001
Male gender (n, [%]) 20 (35 %) 41 (42 %) 21 (42 %) P = 0.62
Body mass index (mean, SD) 29.6 ± 6.5 31.2 ± 6.5 34.6 ± 9.3 P < 0.01
Never smoked (n, [%]) 49 (85 %) 86 (88 %) 42 (82 %) P = 0.29
Physical therapy (n, [%]) 27 (47 %) 44 (45 %) 20 (39 %) P = 0.72
Daily analgesics (n, [%]) 23 (40 %) 41 (42 %) 26 (51 %) P = 0.39
Knee bracing (n, [%]) 20 (35 %) 60 (61 %) 31 (61 %) P < 0.01
Fish oil (n, [%]) 43 (74 %) 64 (65 %) 43 (84 %) P = 0.05
Function index baseline (mean, SD) 34.7 ± 16.1 46.0 ± 15.4 48.1 ± 13.3 P < 0.0001
Index at 6 months (mean, SD) 27.2 ± 15.9 26.3 ± 14.9 36.4 ± 17.7 P < 0.01
Mean improvement (±SD) 6.7 ± 19.0 19.3 ± 16.8 12.5 ± 14.6 P < 0.001
Percentage improvement (±SD) 19 % ± 32 % 40 % ± 32 % 26 % ± 31 % P < 0.001
>9-point improvement (n, [%]) 32 (55 %) 67 (68 %) 26 (51 %) P = 0.07
Average pain baseline (mean, SD) 5.5 ± 2.5 6.2 ± 2.1 7.1 ± 2.1 P < 0.01
Pain at 6 months (mean, SD) 3.9 ± 2.0 3.8 ± 2.1 5.2 ± 2.5 P < 0.01
Mean improvement (mean, SD) 1.66 ± 2.1 2.74 ± 2.5 2.3 ± 2.8 P = 0.05
Percentage improvement (±SD) 21 % ± 38 % 40 % ± 37 % 25 % ± 47 % P = 0.04
Univariate analysis of patient demographics and treatment outcomes relative to knee osteoarthritis (OA) severity (grades 2–4). Data are presented as the mean ±
standard deviation (SD) or percent (%) within OA grade
Table 2 Regression analysis of significant covariates for clinical improvement
OA grade 2 (n = 58) OA grade 3 (n = 98) OA grade 4 (n = 51)
Function index linear regression Parameter estimate P value Parameter estimate P value Parameter estimate P value
Knee bracing +2.69 0.67 +2.56 0.51 +10.81 0.04
Daily analgesics −5.58 0.38 −8.6 0.03 −13.94 0.003
Logistic regression (>9-point improvement) Odds ratio [95 % C.I.] P value Odds ratio [95 % C.I.] P value Odds ratio [95 % C.I.] P value
Knee bracing 2.4 [0.66–8.81] 0.19 1.22 [0.45–2.22] 0.70 5.54 [1.14–27.0] 0.03
Daily analgesics 0.12 [0.03–0.53] 0.005 0.55 [0.18–1.63] 0.28 0.12 [0.03–0.61] 0.009
Average pain index linear regression Parameter estimate P value Parameter estimate P value Parameter estimate P value
Knee bracing +0.94 0.25 +0.30 0.67 +1.81 0.10
Daily analgesics −0.59 0.46 −1.06 0.14 −2.15 0.03
Physical therapy +2.11 0.004 −0.25 0.73 −1.30 0.22
In addition to intra-articular HA injection, knee bracing significantly improved clinical outcomes with positive (+) effect on clinical indices at 6 months in severe
(grade 4) osteoarthritis (OA) analyzed by both linear and logistic regression. In contrast, daily analgesic use was a sign of poor clinical response to treatment with
worsening scores (−)
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Discussion
Intra-articular HA knee injections are commonly per-
formed by orthopedic surgeons [13] and increasingly by
primary care physicians [5]. Although recent meta-
analyses provide conflicting opinions about the efficacy of
HA injections [6–8], it should be no surprise that
image-guided injections may yield significantly better
results [9, 10]. Our retrospective analysis of fluoroscopy-
guided HA knee injections supports this conclusion. More-
over, our multivariate regression analysis reveals OA grade
and bracing may significantly affect clinical outcomes.
Most of the image-guidance literature centers on cor-
ticosteroid injections. For example, Jones et al. [10]
reported that ultrasound guidance yielded clinically
significant improvement in 28/54 (52 %) of their study
subjects, while only 7/30 (23 %) showed improvement
without imaging. They attributed this discrepancy to in-
correctly placed injections, which missed the joint space.
Indeed, meta-analyses have shown that image-guided
intra-articular knee injections yield ~97 % accuracy for
needle placement compared with ~81 % accuracy with-
out imaging [9], which of course means better efficacy
and increased cost-effectiveness [14, 15].
An important limitation of our retrospective case
series is the fact that all the study subjects received
image-guided injections. They were not randomized into
guided and non-guided HA injections for comparison.
However, our data suggest future studies should test
whether guidance together with knee bracing improves
short-term and long-term outcomes when treating knee
OA with HA. This is especially important for severe
disease, which is a group most likely to require joint
replacement and may benefit most from combined HA
injection and knee bracing.
Analgesic use showed no positive effects in our data,
and the literature suggests they have little clinical effect
[16]. Notably, daily analgesic use was not prescribed in
our study. Patients who reported daily analgesic use
were more likely to have high-grade disease, less likely
to show a functional improvement by 6 months, and less
likely to report a reduction in the subjective pain index
relative to baseline. We therefore suspect these patients
may be more likely to be long-term non-responders to
HA injection and knee bracing. This data also suggest
the mechanism of action of HA injections may not be
solely anti-inflammatory.
The biological actions of HA viscosupplementation are
only beginning to be understood. For example, HA may
increase synovial fluid viscosity [17] and regulate a num-
ber of cytokines involved in both anti-inflammatory
activity and extracellular matrix restorative mechanisms.
Recent studies exploring the effects of HA on acti-
vated CD4 positive T cells in synovial fluid [18] and
reduction of joint tissue catabolism [19] are intriguing.
Both mechanisms suggest that in some patients HA may
have more long-term positive effects than only short-term
improvements in pain and patient function. Long-term
outcome data were not available for our analysis, but they
are needed to test whether image-guided HA injections
with knee bracing may delay joint replacement. Over 75 %
of OA patients with joint space narrowing progress to
total knee replacement within 18 years of diagnosis [20].
Delaying joint replacement is therefore very important be-
cause the lifespan of the device is 10–15 years. In an obese
aging population, cost-effective interventions like HA in-
jection and knee bracing make sense.
Conclusions
Our data suggest image-guided HA injections coupled
with knee bracing may benefit patients with moderate to
severe knee osteoarthritis. With the current rates of obes-
ity and the advanced aging of the population, it is reason-
able to speculate that many more patients will require
revision surgery if alternative intervention methods like
viscosupplementation are not effective. A randomized
prospective trial to thoroughly evaluate the short-term
and long-term impact of image-guided HA injection with
and without knee bracing is needed.
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